Effect of the Aikekang Capsule on Immunity in the Mice with Infection of Friend Leukemia Virus

LIU Fang-zhou; LIANG Rui-feng; WANG Xiao-li; GUO Jian-zhong

您当前的位置：

首页 >

文章列表页 >

Effect of the Aikekang Capsule on Immunity in the Mice with Infection of Friend Leukemia Virus

更新时间：2024-01-04

- Effect of the Aikekang Capsule on Immunity in the Mice with Infection of Friend Leukemia Virus
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 18, Issue 19, Pages: 198-201(2012)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2012
- 稿件说明：
移动端阅览
LIU Fang-zhou, LIANG Rui-feng, WANG Xiao-li, et al. Effect of the Aikekang Capsule on Immunity in the Mice with Infection of Friend Leukemia Virus[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(19): 198-201.
DOI：

LIU Fang-zhou, LIANG Rui-feng, WANG Xiao-li, et al. Effect of the Aikekang Capsule on Immunity in the Mice with Infection of Friend Leukemia Virus[J]. Chinese journal of experimental traditional medical formulae, 2012, 18(19): 198-201. DOI：

摘要

目的:观察艾可康胶囊对Friend型白血病鼠的治疗作用。方法:BALB/c小鼠70只

分为正常对照组、模型对照组、齐多夫定对照组(0.1g·kg-1)、唐草片对照组(3.2g·kg-1)、艾可康高、中、低剂量组(5

2.5

1.25g·kg-1);除正常组外

每只小鼠ip0.5mLFLV病毒稀释液

正常组给予0.5mL生理盐水。24h后开始给药

正常对照组和模型对照组给予生理盐水

连续给药21d。末次给药后取血

摘取脾脏。称取脾脏质量

计算脾指数

流式细胞仪测定CD4+

CD8+及CD4+

CD8+T淋巴细胞的幼稚细胞和记忆细胞。结果:与模型组相比较

艾可康高、中剂量组的脾指数、CD4+T淋巴细胞的记忆细胞均显著降低

CD4+

CD4+/CD8+

CD4+T淋巴细胞的幼稚细胞百分率

CD8+T淋巴细胞的幼稚细胞百分率均显著升高(P<0.05)

艾可康高剂量组CD8+均显著升高

CD8+T淋巴细胞的记忆细胞百分率均显著降低(P<0.05)。结论:艾可康胶囊可提高Friend型白血病鼠的免疫功能。

Abstract

Objective:To observe the therapeutic effect of the Aikekang capsule on the infection of Friend leukemia virus in mice. Method:Seventy BALB/c mice were randomly divided into seven groups:normal group

model group

Zidovudine group(0.1 g·kg-1)

Tangcaopian group(3.2 g·kg-1)

Aikekang groups (5

2.5

1.25 g·kg-1). Except for the normal group

the mice in other groups were inoculated intraperitoneally with Friend leukemia virus(FLV) to acquired immuno defiency syndrom (AIDS) model. Twenty-four hours after inoculation

the mice were given corresponding drugs according to the experimental design for 21 days. After treatment

the mice were executed and the effects of the Aikekang capsule on the spleen index

CD4+cells and CD8+cells

CD4+and CD8+T cells were determined. Result:High-dose and middle-dose Aikekang had reduced the spleen index and the percentage of CD4+memory T cell and rised the percentage of CD4+

the ratio of CD4+/CD8+

the percentage of CD4+immature T cell and the percentage of CD8+immature T cell; High-dose Aikekang increased the percentage of CD8+and reduced the percentage of CD8+memory T cell. Conclusion:The Aikekang capsule can enhance the immunity on the infection of Friend leukemia virus in mice.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta Analysis of Clinical Research Literature on Traditional Chinese Medicine Treatment for HIV/AIDS and Related Symptoms

Survey Questionnaires on Diagnosis and Treatment Procedures for Blood Side Effects Related to AIDS HAART Drugs by Traditional Chinese Medicine

Study on Standardization Research of AIDS Traditional Chinese Medicine Syndromes

Analysis on Prescription Rule of Chinese Medicine for AIDS by Retrospective Study Based on Complex Network Analysis

Related Author

ZHANG Miao2

LIANG Mu-hua2

PAN Wan-qi2

XIE Zhong-li2

LIU Ai-hua2

GUO Xuan-xian2

XU Qian-lei2

Related Institution

Henan University of Traditional Chinese Medicine

School of Nursing,Peking University Health Science Center

Medical Service Division,Henan Armed Police Hospital

1,2),XIE Shi-ping~2,LI Su-xiang~2,XU Qian-lei~

河南中医学院艾滋病研究所

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰